Insulin Glargine (new formulation)
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Insulin Glargine (new formulation), covering 2011-06-01 to 2022-04-25. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy [Phase 3]